Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015

Insights

Invasive fusariosis (IF) is increasingly seen in nonneutropenic patients. Persistent neutropenia is the primary risk factor for death in IF patients, irrespective of antifungal treatment.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Epidemiology

Background:

  • Invasive fusariosis (IF) is a serious fungal infection typically linked to severe neutropenia in patients with hematologic conditions.
  • Recent observations suggest a potential rise in IF cases among nonneutropenic individuals.

Purpose of the Study:

  • To investigate the epidemiological trends of invasive fusariosis in Spain between 2000 and 2015.
  • To characterize the clinical features and risk factors associated with mortality in IF patients, particularly focusing on neutropenic status.

Main Methods:

  • A retrospective observational study was conducted across 18 Spanish hospitals.
  • Data on IF cases, patient characteristics (including neutropenic status and comorbidities), and outcomes were collected from 2000 to 2015.
  • Multivariate Cox regression analysis was employed to identify independent risk factors for death.

Main Results:

  • The incidence of IF in nonneutropenic patients increased from 0.08 to 0.22 cases per 100,000 admissions between the periods 2000-2009 and 2010-2015.
  • Nonneutropenic IF patients frequently presented with nonhematologic comorbidities like chronic cardiac/lung disease, rheumatoid arthritis, or a history of solid organ transplantation.
  • The 90-day mortality rate was significantly higher in patients with persistent neutropenia (91.3%) compared to those who were nonneutropenic (28.6%) or had resolved neutropenia (38.1%).

Conclusions:

  • Persistent neutropenia emerged as the sole independent risk factor for mortality in invasive fusariosis patients.
  • Antifungal therapy did not alter the significant impact of persistent neutropenia on survival outcomes.
  • The rising incidence of IF in nonneutropenic patients warrants further investigation into underlying risk factors and management strategies.